AboueshA, StoneC, HobbsWR: Antimicrobial-induced mania (antibiomania): A review of spontaneous reports. J Clin Psychopharmacol, 22:71–81, 2002.
2.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 5th ed. Washington, DC: American Psychiatric Association; 2013.
3.
AoyamaF, IidaJ, InoueM, IwasakaH, SakiyamaS, HataK, KishimotoT: Brain imaging in childhood- and adolescence-onset schizophrenia associated with obsessive-compulsivesymptoms. Acta Psychiatr Scand, 102:32–37, 2000.
4.
AttademoL, De GiorgioG, QuartesanR, MorettiP: Schizophrenia and obsessive-compulsive disorder: from comorbidity to schizo-obsessive disorder. Riv Psichiatr, 47:106–115, 2012.
5.
AyiekoJ, AbuogiL, SimchowitzB, BukusiEA, SmithAH, ReingoldA: Efficacy of isoniazid prophylactic therapy in prevention of tuberculosis in children: A meta-analysis. BMC Infect Dis, 20;14:91, 2014.
CicekE, SutcuR, GokalpO, YilmazHR, OzerMK, UzE, OzcelikN, DelibasN: The effects of isoniazid on hippocampal NMDA receptors: protective role of erdosteine. Mol Cell Biochem, 277:131–135, 2005.
8.
DohertyAM, KellyJ, McDonaldC, O'DywerAM, KeaneJ, CooneyJ: A review of the interplay between tuberculosis and mental health. Gen Hosp Psychiatry, 35: 398–406, 2013.
9.
GoodmanWK, PriceLH, RausmussenSA: The Yale–Brown Obsessive Compulsive Scale (Y-BOCS). Part I: Development, use and reliability. Arch Gen Psychiatry, 46:1006–1011, 1989.
10.
GuyW: ECDEU Assessment Manual for Psychopharmacology. Washington DC: U.S. Department of Health, Education and Welfare; 1976.
11.
KassJS, ShanderaWX: Nervous system effects of antituberculosis therapy. CNS Drugs, 24:655–657, 2010.
12.
KayahanB, OzturkO, VeznedarogluB, EraslanD: Obsessive-compulsive symptoms in schizophrenia: Prevalance and clinical correlates. Psychiatry Clin Neurosci, 59:291–295, 2005.
13.
NolfeG, MilanoW, ZontiniG, PetrellaC, De RosaM, Rundle–SmithS, NolfeG: Obsessive-compulsive symptoms in schizophrenia: their relationship with clinical features and pharmacological treatment. J Psychiatr Pract, 16:235–242, 2010.
14.
PatelDD, LawsKR, PadhiA, FarrowJM, MukhopadhayaK, KrishnaiahR, FinebergNA: The neuropsychology of the schizo-obsessive subtype of schizophrenia: A new analysis. Psychol Med, 40:921–933, 2010.
15.
PoyurovskyM, KrissV, WeismanG, FaragianS, SchneidmanM, FuchsC, WeizmanA, WeizmanR: Familial aggregation of schizophrenia-spectrum disorders and obsessive-compulsive associated disorders inschizophrenia probands with and without OCD. Am J Med Genet B Neuropsychiatr Genet, 5:133:31–36, 2005.
16.
RichterMA, de JesusDR, HoppenbrouwersS, DaigleM, DeluceJ, RavindranLN, FitzgeraldPB, DaskalakisZJ: Evidence for cortical inhibitory and excitatory dysfunction in obsessive compulsive disorder. Neuropsychopharmacology, 37:1144–1151, 2012.
17.
SwetsM, DekkerJ, van Emmerik-van OortmerssenK, SmidGE, SmitF, de HaanL, SchoeversRA: The obsessive compulsive spectrum in schizophrenia, a meta-analysis and meta-regression exploring prevalencerates. Schizophr Res, 152:458–468, 2014.
18.
World Health Organization: Global Tuberculosis Report. Geneva, Switzerland: World Health Organization; 2012.
